The latest biotech news

News and Trends 16 Jan 2025

Top biotech deals of December 2024

The month of December saw a variety of biotech deals take place to advance therapies across different stages in development.

January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter

First ever in vivo CAR gene therapy trial in Europe

News and Trends 10 Jan 2025

The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy

A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region.

January 10, 2025 - 5 minutesmins - By Roohi Mariam Peter

News and Trends 9 Jan 2025

Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground

Explore advances in von Willebrand disease treatment, including Star Therapeutics’ VGA039, and other key players in the space.

January 9, 2025 - 7 minutesmins - By Jules Adam

News and Trends 2 Jan 2025

A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development

Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK.

January 2, 2025 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 12 Dec 2024

Top biotech deals of November 2024

November has seen a variety of biotech deals take place to advance therapies across different stages in development.

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

Trump’s healthcare cabinet picks: Implications for U.S. biopharma

News and Trends 29 Nov 2024

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.?

November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

News and Trends 25 Nov 2024

Evotec on the brink of acquisition: At what cost for the biotech industry?

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape.

November 25, 2024 - 8 minutesmins - By Jules Adam

News and Trends 4 Nov 2024

Top biotech deals of October 2024

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 31 Oct 2024

Halloween biotech stories: Unveiling scientists’ worst fears

What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.

October 31, 2024 - 15 minutesmins - By Jules Adam

News and Trends 24 Oct 2024

Fighting severe epilepsies: A new era for Dravet syndrome treatment?

Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.

October 24, 2024 - 10 minutesmins - By Jules Adam

News and Trends 23 Oct 2024

RNA editing in humans: the race begins with first successful trial

Wave Life Sciences achieves RNA editing in the clinic, crossing a major milestone in the space.

October 23, 2024 - 6 minutesmins - By Roohi Mariam Peter

cellular reprogramming with Shift Bioscience

News and Trends 21 Oct 2024

Turning back time with cellular reprogramming: Shift raises $16 million in seed funding

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.

October 21, 2024 - 9 minutesmins - By Jules Adam

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Top biotech deals of December 2024

The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy

Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground

A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development

Top biotech deals of November 2024

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Evotec on the brink of acquisition: At what cost for the biotech industry?

Top biotech deals of October 2024

Halloween biotech stories: Unveiling scientists’ worst fears

Fighting severe epilepsies: A new era for Dravet syndrome treatment?

RNA editing in humans: the race begins with first successful trial

Turning back time with cellular reprogramming: Shift raises $16 million in seed funding

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!